SuperworthKewaunee Scientific EPS KEQU
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jul 31, 2026
- $2.76
- Latest quarter, Q1 FY27
- $0.58
- −44% on a year earlier
- Fiscal year 2026
- $3.22
- −16% on the year before
Kewaunee Scientific's earnings per share was $2.76 over the twelve months to Jul 31, 2026, down 33% on a year earlier.
In its latest quarter, Q1 FY27, it was $0.58, down 44% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | $3.22 | −16% |
| FY2025 | $3.83 | −40% |
| FY2024 | $6.35 | +2546% |
| FY2023 | $0.24 | n/a |
| FY2022 | −$2.19 | n/a |
| FY2021 | −$1.34 | n/a |
| FY2020 | −$1.71 | −417% |
| FY2019 | $0.54 | −72% |
| FY2018 | $1.90 | +14% |
| FY2017 | $1.66 | +17% |
| FY2016 | $1.42 | +7% |
| FY2015 | $1.33 | −10% |
| FY2014 | $1.48 | +26% |
| FY2013 | $1.17 | +193% |
| FY2012 | $0.40 | −44% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY27 | $0.58 | −44% | $2.76 | |
| Q4 FY26 | $1.13 | −31% | $3.22 | |
| Q3 FY26 | $0.23 | −49% | $3.72 | |
| Q2 FY26 | $0.82 | −19% | $3.94 | |
| Q1 FY26 | $1.04 | +41% | $4.13 | |
| Q4 FY25 | $1.63 | −56% | $3.83 | |
| Q3 FY25 | $0.45 | −47% | $5.91 | |
| Q2 FY25 | $1.01 | +9% | $6.31 | |
| Q1 FY25 | $0.74 | −14% | $6.23 | |
| Q4 FY24 | $3.71 | +960% | $6.35 | |
| Q3 FY24 | $0.85 | +240% | $2.99 | |
| Q2 FY24 | $0.93 | n/a | $2.39 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Kewaunee Scientific's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| NEPHNephros | $0.16 | +33% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| MOVMovado | $1.80 | +137% a year |
| Peer median | $1.08 |
Where Kewaunee Scientific ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Kewaunee Scientific
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.